Scott Liu

Dr. Liu has more than 25 years of experience in biopharmaceutical R&D, manufacturing, and quality management. Dr. Liu previously retired from Shanghai Henlius Biotech, Inc. (2696.HK) which he Co-Founded in 2010, held positions as President & CEO, and was integral in building the company to have a valuation of over 20 Billion HKD. Prior to Co-Founding Henlius, he held several executive positions, including Vice President at United Biomedical as well as holding executive positions in quality at Bristol-Myers Squibb and Amgen. Dr. Liu received his Ph.D. degree in Biology from Purdue University with postdoctoral training in Biology at Stanford University.